Tumor incidence and cellularity in lungs of mice given various dose schedules of urethan
White, M.R.; Grendon, A.; Jones, H.B.
Cancer Research 30(4): 1030-1036
1970
ISSN/ISBN: 0008-5472 PMID: 5504345 Document Number: 19695
Document emailed within 1 workday
Related Documents
Iunker, V.M.; Arkhipov, S.A.; Gruntenko, E.V. 1984: Ambiguous action of splenocytes from tumor-bearing mice on the formation of metastases in the lungs of mice in an adaptive transfer system Biulleten' Eksperimental'noi Biologii i Meditsiny 98(11): 598-600Gurr, M.I.; Kirtland, J. 1978: Adipose tissue cellularity: a review. I. Techniques for studying cellularity International Journal of Obesity 2(4): 401-427
Chernozemski, I.N.; Warwick, G.P. 1970: Liver regeneration and induction of hepatomas in B6AF mice by urethan Cancer Research 30(11): 2685-2690
Goldfeder, A. 1972: Electron microscopic study of neoplasms induced by urethan and x-rays in X-Gf mice Cancer Research 32(12): 2778-2792
Ranadive, D.V.; Arjungi, K.N.; Bhide, S.V. 1973: Effect of N-hydroxy urethan on nucleic acid biosynthesis in Swiss mice Indian Journal of Cancer 10(3): 333-337
Gorelik, E.; Herberman, R.B. 1981: Susceptibility of various strains of mice to urethan-induced lung tumors and depressed natural killer cell activity Journal of the National Cancer Institute 67(6): 1317-1322
Nakata, T. 1972: The accelerating effect of heat-denatured isogeneic spontaneous mammary tumor cells on spontaneous tumor incidence in female C3H mice and the effect of time of injection Cancer Research 32(11): 2304-2306
Frigeri, L.G.; Wolff, G.L.; Teguh, C. 1988: Differential responses of yellow Avy/A and agouti A/a (BALB/c X VY) F1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity International Journal of Obesity 12(4): 305-320
Crispens, C.G.; Sorenson, J.R. 1990: Combination therapy with CuDIPS, Tween 80 and cyclophosphamide: effects on survival and tumor incidence in SJL/J mice In Vivo 4(5): 321-323
Jaffe, D.; Bowden, G.T. 1987: Ionizing radiation as an initiator: effects of proliferation and promotion time on tumor incidence in mice Cancer Research 47(24 Part 1): 6692-6696
Mokyr, M.B.; Barker, E.; Weiskirch, L.M.; Takesue, B.Y.; Pyle, J.M. 1989: Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor Cancer Research 49(16): 4597-4606
Jones, S.F.; Burris, H.A.; Hainsworth, J.D.; Yardley, D.A.; Raefsky, E.A.; Miranda, F.T.; Kuzur, M.E.; Willcutt, N.T.; White, M.B.; Greco, F.Anthony. 2003: Phase I. Trial of irinotecan plus carboplatin in two dose schedules Oncology 17(5 Suppl. 5): 36-40
Rubin, M.; Bluestone, J.A.; Newell, K.A.; Prokhorova, A.; Mokyr, M.B. 1994: Cooperation between staphylococcal enterotoxin B and low dose melphalan in the cure of mice bearing a large MOPC-315 tumor and extensive metastases Journal of Immunology 152(7): 3522-3529
Band, P.R.; Ross, C.A.; Holland, J.F. 1973: Comparison of two dose schedules of dichloromethotrexate (NSC-29630) in lung cancer Cancer ChemoTherapy Reports 57(1): 79-82
Fowler, J.F. 1975: Dose fractionation schedules--biologic aspects and applications to high LET radiotherapy Journal of the Canadian Association of Radiologists 26(1): 40-43
Bremme, K.; Kindahl, H.; Svanborg, K. 1980: Induction of labor by oral PGE2 administration--evaluation of different dose schedules Acta Obstetricia et Gynecologica Scandinavica. Suppl 92: 5-10
Zaichkina, S.I.; Rozanova, O.M.; Diukina, A.R.; Simonova, N.B.; Romanchenko, S.P.; Sorokina, S.S.; Aptikaeva, G.F.; Iusupov, V.I. 2013: Influence of low-dose-rate red and near-infrared radiations on the level of reactive oxygen species, the genetic apparatus and the tumor growth in mice in vivo Biofizika 58(5): 897-903
Kallman, R.F.; Jardine, L.J.; Johnson, C.W. 1970: Effects of different schedules of dose fractionation on the oxygenation status of a transplantable mouse sarcoma Journal of the National Cancer Institute 44(2): 369-377
Mitani, M.; Mori, K.; Himeno, K.; Nomoto, K. 1989: Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic murine tumor. Comparison between neonatally thymectomized mice and congenitally athymic nude mice Journal of Immunology 142(6): 2148-2154
Brosjö, O.; Bauer, H.C.; Broström, L.A.; Nilsson, O.S.; Reinholt, F.P.; Tribukait, B. 1987: Growth inhibition of human osteosarcomas in nude mice by human interferon-alpha: significance of dose and tumor differentiation Cancer Research 47(1): 258-262